These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37434429)
1. Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population-based study. How GY; Kuick CH; Yong MH; Soh SY; Hee EX; Wong MK; Quek R; Harunal MF; Selvarajan S; Sittampalam K; Dhamne CA; Lee V; Chang KT; Loh AH Asia Pac J Clin Oncol; 2023 Jul; ():. PubMed ID: 37434429 [TBL] [Abstract][Full Text] [Related]
2. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Rekhi B; Upadhyay P; Ramteke MP; Dutt A Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493 [TBL] [Abstract][Full Text] [Related]
3. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563 [TBL] [Abstract][Full Text] [Related]
4. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience. Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515 [TBL] [Abstract][Full Text] [Related]
6. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis]. Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817 [No Abstract] [Full Text] [Related]
7. The current landscape of rhabdomyosarcomas: an update. Leiner J; Le Loarer F Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361 [TBL] [Abstract][Full Text] [Related]
8. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review. Kohashi K; Kinoshita I; Oda Y Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473 [TBL] [Abstract][Full Text] [Related]
9. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases]. Yang L; Zhang HJ; Yang SJ Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670 [No Abstract] [Full Text] [Related]
10. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome. Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110 [TBL] [Abstract][Full Text] [Related]
11. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Rudzinski ER; Anderson JR; Hawkins DS; Skapek SX; Parham DM; Teot LA Arch Pathol Lab Med; 2015 Oct; 139(10):1281-7. PubMed ID: 25989287 [TBL] [Abstract][Full Text] [Related]
12. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases. Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226 [TBL] [Abstract][Full Text] [Related]
17. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues]. Mentzel T Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735 [TBL] [Abstract][Full Text] [Related]
18. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347 [TBL] [Abstract][Full Text] [Related]
19. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Folpe AL; McKenney JK; Bridge JA; Weiss SW Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis. Amer KM; Thomson JE; Congiusta D; Dobitsch A; Chaudhry A; Li M; Chaudhry A; Bozzo A; Siracuse B; Aytekin MN; Ghert M; Beebe KS J Orthop Res; 2019 Oct; 37(10):2226-2230. PubMed ID: 31161653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]